BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19895789)

  • 1. Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach.
    Lee J; Choi K; Choi C
    Biochem Biophys Res Commun; 2010 Jan; 391(1):33-7. PubMed ID: 19895789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
    Wyke SM; Tisdale MJ
    Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic protein complexes regulate NF-kappaB signaling.
    Wegener E; Krappmann D
    Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
    Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
    Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK).
    Qing G; Yan P; Xiao G
    Cell Res; 2006 Nov; 16(11):895-901. PubMed ID: 17088896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
    Scheidereit C
    Oncogene; 2006 Oct; 25(51):6685-705. PubMed ID: 17072322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells.
    Park KA; Byun HS; Won M; Yang KJ; Shin S; Piao L; Kim JM; Yoon WH; Junn E; Park J; Seok JH; Hur GM
    Carcinogenesis; 2007 Jan; 28(1):71-80. PubMed ID: 16774932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-kappaB p65 and impairs NF-kappaB activity by inhibiting proteasome activity of cerebellar neurons.
    Wang HL; He CY; Chou AH; Yeh TH; Chen YL; Li AH
    Cell Signal; 2007 Mar; 19(3):573-81. PubMed ID: 17005371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the signal dynamics of activated form of IKK on NF-kappaB and anti-apoptotic gene expressions: a systems biology approach.
    Park SG; Lee T; Kang HY; Park K; Cho KH; Jung G
    FEBS Lett; 2006 Feb; 580(3):822-30. PubMed ID: 16413545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.
    Wullaert A; Heyninck K; Janssens S; Beyaert R
    Trends Immunol; 2006 Nov; 27(11):533-40. PubMed ID: 16982211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
    Schmid JA; Birbach A
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB activation: Nondegradative ubiquitination implicates NEMO.
    Israël A
    Trends Immunol; 2006 Sep; 27(9):395-7. PubMed ID: 16857427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative UPS drug targets upstream the 26S proteasome.
    Hjerpe R; Rodríguez MS
    Int J Biochem Cell Biol; 2008; 40(6-7):1126-40. PubMed ID: 18203645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
    Perkins ND
    Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse ubiquitin signaling in NF-κB activation.
    Iwai K
    Trends Cell Biol; 2012 Jul; 22(7):355-64. PubMed ID: 22543051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.